{"id":"https://openalex.org/W2276035339","doi":"https://doi.org/10.1111/bjd.14493","title":"A prospective phase III, randomized, double\u2010blind, placebo\u2010controlled study of brodalumab in patients with moderate\u2010to\u2010severe plaque psoriasis","display_name":"A prospective phase III, randomized, double\u2010blind, placebo\u2010controlled study of brodalumab in patients with moderate\u2010to\u2010severe plaque psoriasis","publication_year":2016,"publication_date":"2016-02-25","ids":{"openalex":"https://openalex.org/W2276035339","doi":"https://doi.org/10.1111/bjd.14493","mag":"2276035339","pmid":"https://pubmed.ncbi.nlm.nih.gov/26914406"},"language":"en","primary_location":{"id":"doi:10.1111/bjd.14493","doi":"https://doi.org/10.1111/bjd.14493","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjd.14493","pdf_url":"https://academic.oup.com/bjd/article-pdf/175/2/273/47554194/bjd0273.pdf","source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/bjd/article-pdf/175/2/273/47554194/bjd0273.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008286260","display_name":"Kim Alexander Papp","orcid":"https://orcid.org/0000-0001-9557-3642","observed_orcids":["https://orcid.org/0000-0001-9557-3642"]},"institutions":[{"id":"https://openalex.org/I4210122653","display_name":"Probity Medical Research","ror":"https://ror.org/0222df516","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210122653"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"K.A. Papp","raw_affiliation_strings":["Probity Medical Research and K Papp Clinical Research Waterloo ON Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Probity Medical Research and K Papp Clinical Research Waterloo ON Canada","institution_ids":["https://openalex.org/I4210122653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000572878","display_name":"Kristian Reich","orcid":"https://orcid.org/0000-0001-5248-4332","observed_orcids":["https://orcid.org/0000-0001-5248-4332"]},"institutions":[{"id":"https://openalex.org/I4210151227","display_name":"Dermatologikum Hamburg","ror":"https://ror.org/04whsde46","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210151227"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Reich","raw_affiliation_strings":["Dermatologikum Hamburg and SCIderm Research Institute Hamburg Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatologikum Hamburg and SCIderm Research Institute Hamburg Germany","institution_ids":["https://openalex.org/I4210151227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082011794","display_name":"Carle F. Paul","orcid":"https://orcid.org/0000-0003-0165-5263","observed_orcids":["https://orcid.org/0000-0003-0165-5263"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Paul","raw_affiliation_strings":["Paul Sabatier University Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paul Sabatier University Toulouse France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080237247","display_name":"Andrew Blauvelt","orcid":"https://orcid.org/0000-0002-2633-985X","observed_orcids":["https://orcid.org/0000-0002-2633-985X"]},"institutions":[{"id":"https://openalex.org/I4210127914","display_name":"Oregon Medical Research Center","ror":"https://ror.org/03m027021","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210127914"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Blauvelt","raw_affiliation_strings":["Oregon Medical Research Center Portland OR U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Medical Research Center Portland OR U.S.A","institution_ids":["https://openalex.org/I4210127914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089986285","display_name":"Wojciech Baran","orcid":"https://orcid.org/0000-0003-2732-3494","observed_orcids":["https://orcid.org/0000-0003-2732-3494"]},"institutions":[{"id":"https://openalex.org/I385303915","display_name":"Wroclaw Medical University","ror":"https://ror.org/01qpw1b93","country_code":"PL","type":"education","lineage":["https://openalex.org/I385303915"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"W. Baran","raw_affiliation_strings":["Wroclaw Medical University Wroclaw Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wroclaw Medical University Wroclaw Poland","institution_ids":["https://openalex.org/I385303915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113659854","display_name":"Chantal Bolduc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138799","display_name":"Innovaderm (Canada)","ror":"https://ror.org/0486db050","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210138799"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C. Bolduc","raw_affiliation_strings":["The University of Montreal and Innovaderm Research Montreal QC Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Montreal and Innovaderm Research Montreal QC Canada","institution_ids":["https://openalex.org/I4210138799","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112569850","display_name":"D. Toth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122653","display_name":"Probity Medical Research","ror":"https://ror.org/0222df516","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210122653"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Toth","raw_affiliation_strings":["XLR8 Medical Research and Probity Medical Research Windsor ON Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"XLR8 Medical Research and Probity Medical Research Windsor ON Canada","institution_ids":["https://openalex.org/I4210122653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061849637","display_name":"Richard G B Langley","orcid":"https://orcid.org/0000-0003-4730-2164","observed_orcids":["https://orcid.org/0000-0003-4730-2164"]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R.G. Langley","raw_affiliation_strings":["Dalhousie University Halifax NS Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalhousie University Halifax NS Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004761425","display_name":"Jennifer Clay Cather","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Cather","raw_affiliation_strings":["Modern Research Associates Modern Dermatology A Baylor Health Texas Affiliate, and Probity Medical Research Dallas TX U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Modern Research Associates Modern Dermatology A Baylor Health Texas Affiliate, and Probity Medical Research Dallas TX U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049859852","display_name":"Alice Bendix Gottlieb","orcid":"https://orcid.org/0000-0002-2927-8618","observed_orcids":["https://orcid.org/0000-0002-2927-8618"]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.B. Gottlieb","raw_affiliation_strings":["Tufts Medical Center Boston MA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tufts Medical Center Boston MA U.S.A","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085831636","display_name":"Diamant Tha\u00e7i","orcid":"https://orcid.org/0000-0001-8513-550X","observed_orcids":["https://orcid.org/0000-0001-8513-550X"]},"institutions":[{"id":"https://openalex.org/I9341345","display_name":"University of L\u00fcbeck","ror":"https://ror.org/00t3r8h32","country_code":"DE","type":"education","lineage":["https://openalex.org/I9341345"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D. Tha\u00e7i","raw_affiliation_strings":["University of L\u00fcbeck L\u00fcbeck Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of L\u00fcbeck L\u00fcbeck Germany","institution_ids":["https://openalex.org/I9341345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080337749","display_name":"James G. Krueger","orcid":"https://orcid.org/0000-0002-3775-1778","observed_orcids":["https://orcid.org/0000-0002-3775-1778"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.G. Krueger","raw_affiliation_strings":["The Rockefeller University New York NY U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Rockefeller University New York NY U.S.A","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070208317","display_name":"Chris B. Russell","orcid":"https://orcid.org/0000-0002-0240-1815","observed_orcids":["https://orcid.org/0000-0002-0240-1815"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.B. Russell","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110551544","display_name":"Cassandra E. Milmont","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.E. Milmont","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100336820","display_name":"Jing Li","orcid":"https://orcid.org/0000-0001-9141-4433","observed_orcids":["https://orcid.org/0000-0001-9141-4433"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Li","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032504505","display_name":"Paul A. Klekotka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P.A. Klekotka","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018239511","display_name":"Greg Kricorian","orcid":"https://orcid.org/0000-0002-9419-9836","observed_orcids":["https://orcid.org/0000-0002-9419-9836"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Kricorian","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039577185","display_name":"Ajay Nirula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Nirula","raw_affiliation_strings":["Amgen Inc. Thousand Oaks CA U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc. Thousand Oaks CA U.S.A","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5008286260"],"corresponding_institution_ids":["https://openalex.org/I4210122653"],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":{"value":3731,"currency":"GBP","value_usd":4920},"fwci":34.736,"has_fulltext":true,"cited_by_count":471,"citation_normalized_percentile":{"value":0.99882826,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"175","issue":"2","first_page":"273","last_page":"286"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brodalumab","display_name":"brodalumab","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.9800000190734863},{"id":"https://openalex.org/keywords/interleukin-17-receptor","display_name":"interleukin-17 receptor","score":0.8709999918937683},{"id":"https://openalex.org/keywords/anti-cytokine-therapy","display_name":"anti-cytokine therapy","score":0.8270000219345093},{"id":"https://openalex.org/keywords/pasi-75","display_name":"PASI 75","score":0.9300000071525574},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6439999938011169},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9589999914169312}],"concepts":[{"id":"https://openalex.org/C3020604521","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Plaque psoriasis","level":3,"score":0.895155131816864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8295970559120178},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.684346616268158},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6289882063865662},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5962579846382141},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.4482354521751404},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44233065843582153},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.43692445755004883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3534659147262573},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11956796050071716},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.05662429332733154}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019233","descriptor_name":"Retreatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061214","descriptor_name":"Patient Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/bjd.14493","doi":"https://doi.org/10.1111/bjd.14493","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjd.14493","pdf_url":"https://academic.oup.com/bjd/article-pdf/175/2/273/47554194/bjd0273.pdf","source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:26914406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26914406","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1111/bjd.14493","doi":"https://doi.org/10.1111/bjd.14493","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjd.14493","pdf_url":"https://academic.oup.com/bjd/article-pdf/175/2/273/47554194/bjd0273.pdf","source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320322202","display_name":"IC Design Education Center","ror":"https://ror.org/005v57z85"},{"id":"https://openalex.org/F4320337449","display_name":"Janssen Biotech","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2276035339.pdf","grobid_xml":"https://content.openalex.org/works/W2276035339.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1890063097","https://openalex.org/W1973354423","https://openalex.org/W1993273784","https://openalex.org/W1999113825","https://openalex.org/W2022665587","https://openalex.org/W2025888803","https://openalex.org/W2047344004","https://openalex.org/W2058547807","https://openalex.org/W2059556563","https://openalex.org/W2073037264","https://openalex.org/W2093897672","https://openalex.org/W2106176150","https://openalex.org/W2109163445","https://openalex.org/W2121126920","https://openalex.org/W2121900420","https://openalex.org/W2127834887","https://openalex.org/W2150933492","https://openalex.org/W2151566115","https://openalex.org/W2166281097","https://openalex.org/W2171889601","https://openalex.org/W2561759163","https://openalex.org/W4210999603"],"related_works":["https://openalex.org/W7160829381","https://openalex.org/W2127834887","https://openalex.org/W1845936179","https://openalex.org/W2792548292","https://openalex.org/W2587818680","https://openalex.org/W4243900799","https://openalex.org/W3117899918","https://openalex.org/W4382809641","https://openalex.org/W2281847379","https://openalex.org/W4360614555"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,233],"interleukin-17":[2],"cytokine":[3],"family":[4],"plays":[5],"a":[6,21,73],"central":[7],"role":[8],"in":[9,26,45,171,243,252],"psoriasis":[10],"pathogenesis.":[11],"OBJECTIVES:":[12],"To":[13],"evaluate":[14],"the":[15,46,97,113,163],"efficacy":[16],"and":[17,49,174,180,198,209,219,223,247],"safety":[18,234,250],"of":[19,120,165],"brodalumab,":[20],"human":[22],"anti-interleukin-17":[23],"receptor":[24],"antibody,":[25],"treating":[27],"patients":[28,44,80,105,122,144,166,190,253],"with":[29,65,106,112,123,136,148,167,254],"moderate-to-severe":[30,255],"plaque":[31,256],"psoriasis.":[32,257],"METHODS:":[33],"In":[34],"this":[35],"phase":[36],"III,":[37],"double-blind,":[38],"placebo-controlled":[39],"study":[40],"(NCT01708590;":[41],"AMAGINE-1),":[42],"adult":[43],"U.S.A.,":[47],"Canada":[48],"Europe":[50],"were":[51,94,110,134,162,188],"randomized":[52,145],"to":[53,96,146],"brodalumab":[54,82,137,147,155,195,200],"(140":[55,207,221],"or":[56,59,90,99,130,152],"210":[57,138,156,201],"mg)":[58,208,212,222,226],"placebo":[60,98,153],"every":[61],"2":[62,125,151],"weeks":[63,119,129],"(Q2W),":[64],"an":[66,248],"additional":[67],"dose":[68],"at":[69,183],"week":[70,78,103,142,184,204],"1,":[71],"for":[72,126],"12-week":[74],"induction":[75,100,114],"phase.":[76],"At":[77,141,203],"12,":[79,143,205],"receiving":[81],"who":[83],"achieved":[84,216,230],"static":[85],"Physician's":[86],"Global":[87],"Assessment":[88],"0":[89],"1":[91],"(sPGA":[92],"success)":[93],"rerandomized":[95],"dose.":[101,115],"After":[102,116],"16,":[104],"sPGA":[107,124,131,149,181,231],"\u2265":[108,117,127,132,150,168],"3":[109,133],"re-treated":[111],"12":[118],"retreatment,":[121],"4":[128],"rescued":[135],"mg":[139,157,197],"Q2W.":[140,158],"received":[154],"Coprimary":[159],"end":[160],"points":[161],"percentage":[164],"75%":[169],"improvement":[170],"Psoriasis":[172],"Area":[173],"Severity":[175],"Index":[176],"score":[177],"(PASI":[178],"75)":[179],"success":[182],"12.":[185],"RESULTS:":[186],"There":[187],"661":[189],"randomized:":[191],"220":[192],"placebo,":[193],"219":[194],"140":[196],"222":[199],"mg.":[202],"60%":[206],"83%":[210],"(210":[211,225],"vs.":[213,227],"3%":[214],"(placebo)":[215,229],"PASI":[217],"75,":[218],"54%":[220],"76%":[224],"1%":[228],"success.":[232],"profile":[235,251],"was":[236],"considered":[237],"acceptable.":[238],"CONCLUSIONS:":[239],"Brodalumab":[240],"therapy":[241],"resulted":[242],"significant":[244],"clinical":[245],"benefit":[246],"acceptable":[249]},"counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":28},{"year":2024,"cited_by_count":35},{"year":2023,"cited_by_count":35},{"year":2022,"cited_by_count":47},{"year":2021,"cited_by_count":54},{"year":2020,"cited_by_count":78},{"year":2019,"cited_by_count":59},{"year":2018,"cited_by_count":59},{"year":2017,"cited_by_count":41},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}